865186-62-5

Basic information

• Product Name: 2-Bromo-4-fluoro-5-methoxybenzaldehyde
• Synonyms: 2-Bromo-4-fluoro-5-methoxybenzaldehyde
• CAS NO: 865186-62-5
• Molecular Formula: C₈H₆BrFO₂
• Molecular Weight: 233.0344432
• Mol File: 865186-62-5.mol
• Article Data: 6

Chemical Properties

• Melting Point: 100-105°C
• Appearance: /
• CAS DataBase Reference: 2-Bromo-4-fluoro-5-methoxybenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Bromo-4-fluoro-5-methoxybenzaldehyde(865186-62-5)
• EPA Substance Registry System: 2-Bromo-4-fluoro-5-methoxybenzaldehyde(865186-62-5)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26
• WGK Germany: 3
• Hazardous Substances Data: 865186-62-5(Hazardous Substances Data)

Upstream product

• 112204-58-7 5-Bromo-2-fluorophenol 
• 861928-19-0 4,5-dibromo-2-fluoroanisole 
• 68-12-2 N,N-dimethyl-formamide 
• 128495-46-5 4-fluoro-3-methoxybenzaldehyde 
• 112204-57-6 dihydroxy-(5-bromo-2-fluorophenyl)-borane 

Downstream Products

• 865186-63-6 2-Bromo-4-fluoro-5-methoxybenzaldehyde dimethyl acetal 
• 1262989-52-5 2-bromo-4-fluoro-5-hydroxybenzaldehyde 
• 1319804-06-2 4-bromo-2-fluoro-5-(hydroxymethyl)phenol 
• 1319804-07-3 2-(4-bromo-2-fluoro-5-((tetrahydro-2H-pyran-2-yloxy)methyl)phenoxy)tetrahydro-2H-pyran 

Relevant articles and documents

GPR40 AGONISTS

This disclosure is directed, at least in part, to GPR40 agonists useful for the treatment of conditions or disorders involving the gut-brain axis. In some embodiments, the GPR40 agonists are gut-restricted compounds. In some embodiments, the GPR40 agonists are full agonists or partial agonists. In some embodiments, the condition or disorder is a metabolic disorder, such as diabetes, obesity, nonalcoholic steatohepatitis (NASH), or a nutritional disorder such as short bowel syndrome.

Boron-Containing Small Molecules as Anti-Inflammatory Agents

Compounds and methods of treating anti-inflammatory conditions are disclosed.

2-AMINOQUINAZOLINE DERIVATIVE

The present invention provides a compound represented by Formula (I) (wherein R 1 and R 2 are the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl and the like, R 3 represents substituted or unsubstituted aryl, a substituted or unsubstituted aromatic heterocyclic group and the like, R 4 and R 5 are the same or different, and each represents a hydrogen atom, halogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl and the like, proviso that they are not simultaneously hydrogen atoms, and R 6 represents hydroxy or substituted or unsubstituted lower alkoxy), or a pharmaceutically acceptable salt thereof and the like.